Bioelectronics Corp (BIEL)

[srinsocal]

Thanks for sharing CCS, I think that we saw the shift to a Partnership model in Q1 2018. The drastic reduction in Advertising Expense was a good indicator that they no longer felt spending $130k a Quarter was giving an acceptable ROI.

Q1 would have been the time frame of high interest from Bayer and most likely several other potential Partners due to the NHS news. Why go in further debt for millions to finance a Consumer Education/Marketing Campaign when partnering with a multi billion dollar Big Pharma Company can give you instant credibility/notoriety??

Similar model with the NHS. The NHS has run deficits for years and they either need to cut costs or raise taxes. BIEL showed them how they can cut costs and improve the quality of life for chronic pain patients. Win/Win for BIEL and NHS. The NHS promotes ActiPatch internally, ActiPatch saves the money that a UK marketing campaign would cost and gets the association with a Healthcare Icon.

Just selling the IP would be another step down that road and it makes a lot of sense. Fund your R and D, keep cranking out the new indications, let Big Pharma manufacture and market while you cash a royalty check every month.

I wish you an enjoyable trip to Frederick!